These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27273074)

  • 1. The complement system, neuronal injury, and cognitive function in horizontally-acquired HIV-infected youth.
    McGuire JL; Gill AJ; Douglas SD; Kolson DL;
    J Neurovirol; 2016 Dec; 22(6):823-830. PubMed ID: 27273074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders.
    McGuire JL; Gill AJ; Douglas SD; Kolson DL;
    J Neurovirol; 2015 Aug; 21(4):439-48. PubMed ID: 25776526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
    Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
    EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cell-free mitochondrial DNA is a marker of ongoing inflammation and better neurocognitive function in virologically suppressed HIV-infected individuals.
    Pérez-Santiago J; De Oliveira MF; Var SR; Day TRC; Woods SP; Gianella S; Mehta SR
    J Neurovirol; 2017 Apr; 23(2):283-289. PubMed ID: 27921220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
    Jespersen S; Pedersen KK; Anesten B; Zetterberg H; Fuchs D; Gisslén M; Hagberg L; Trøseid M; Nielsen SD
    BMC Infect Dis; 2016 Apr; 16():176. PubMed ID: 27103116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Tat causes synapse loss in a mouse model of HIV-associated neurocognitive disorder that is independent of the classical complement cascade component C1q.
    Hammond JW; Qiu WQ; Marker DF; Chamberlain JM; Greaves-Tunnell W; Bellizzi MJ; Lu SM; Gelbard HA
    Glia; 2018 Dec; 66(12):2563-2574. PubMed ID: 30325063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.
    Guha D; Mukerji SS; Chettimada S; Misra V; Lorenz DR; Morgello S; Gabuzda D
    AIDS; 2019 Mar; 33(4):615-625. PubMed ID: 30557159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus.
    Michailidou I; Willems JG; Kooi EJ; van Eden C; Gold SM; Geurts JJ; Baas F; Huitinga I; Ramaglia V
    Ann Neurol; 2015 Jun; 77(6):1007-26. PubMed ID: 25727254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Plasma Homocysteine Levels and Neuronal Injury in HIV Infection.
    Ahlgren E; Hagberg L; Fuchs D; Andersson LM; Nilsson S; Zetterberg H; Gisslén M
    PLoS One; 2016; 11(7):e0158973. PubMed ID: 27441551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection.
    Mellgren A; Price RW; Hagberg L; Rosengren L; Brew BJ; Gisslén M
    Neurology; 2007 Oct; 69(15):1536-41. PubMed ID: 17923616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.
    Aeinehband S; Lindblom RP; Al Nimer F; Vijayaraghavan S; Sandholm K; Khademi M; Olsson T; Nilsson B; Ekdahl KN; Darreh-Shori T; Piehl F
    PLoS One; 2015; 10(4):e0122048. PubMed ID: 25835709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.
    Jessen Krut J; Mellberg T; Price RW; Hagberg L; Fuchs D; Rosengren L; Nilsson S; Zetterberg H; Gisslén M
    PLoS One; 2014; 9(2):e88591. PubMed ID: 24523921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection.
    Peluso MJ; Valcour V; Ananworanich J; Sithinamsuwan P; Chalermchai T; Fletcher JL; Lerdlum S; Chomchey N; Slike B; Sailasuta N; Gisslén M; Zetterberg H; Spudich S;
    J Infect Dis; 2015 Dec; 212(11):1759-67. PubMed ID: 25995196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis.
    Gaetani L; Salvadori N; Lisetti V; Eusebi P; Mancini A; Gentili L; Borrelli A; Portaccio E; Sarchielli P; Blennow K; Zetterberg H; Parnetti L; Calabresi P; Di Filippo M
    J Neurol; 2019 Sep; 266(9):2157-2163. PubMed ID: 31129709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function.
    Lindblom RP; Aeinehband S; Ström M; Al Nimer F; Sandholm K; Khademi M; Nilsson B; Piehl F; Ekdahl KN
    Clin Immunol; 2016 May; 166-167():89-95. PubMed ID: 27085202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study.
    Alagaratnam J; De Francesco D; Zetterberg H; Heslegrave A; Toombs J; Kootstra NA; Underwood J; Gisslen M; Reiss P; Fidler S; Sabin CA; Winston A
    J Neurovirol; 2022 Feb; 28(1):54-63. PubMed ID: 34874540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis.
    Le ND; Muri L; Grandgirard D; Kuhle J; Leppert D; Leib SL
    J Neuroinflammation; 2020 Oct; 17(1):293. PubMed ID: 33028339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation in Lyme neuroborreliosis--increased levels of C1q and C3a in cerebrospinal fluid indicate complement activation in the CNS.
    Henningsson AJ; Ernerudh J; Sandholm K; Carlsson SA; Granlund H; Jansson C; Nyman D; Forsberg P; Nilsson Ekdahl K
    J Neuroimmunol; 2007 Feb; 183(1-2):200-7. PubMed ID: 17157926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection.
    Pérez-Santiago J; Schrier RD; de Oliveira MF; Gianella S; Var SR; Day TR; Ramirez-Gaona M; Suben JD; Murrell B; Massanella M; Cherner M; Smith DM; Ellis RJ; Letendre SL; Mehta SR
    J Neurovirol; 2016 Apr; 22(2):191-200. PubMed ID: 26428514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
    Anderson AM; Lennox JL; Mulligan MM; Loring DW; Zetterberg H; Blennow K; Kessing C; Koneru R; Easley K; Tyor WR
    J Neurovirol; 2017 Feb; 23(1):106-112. PubMed ID: 27400930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.